Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.98
+0.08 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $725.31 million as of December 5, 2025. Its market cap has decreased by -34.59% in one year.
Market Cap
725.31M
Enterprise Value
666.42M
1-Year Change
-34.59%
Ranking
Category
Stock Price
$7.98
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $725.31M, an increase of 40.72%. That is a compound annual growth rate of 17.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 725.31M | -30.15% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |